John C. Morris

Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma

John C. Morris, Antoinette R. Tan, Thomas Olencki et al. · PLoS ONE · 2014 · 483 citations · Full text

Medicine, Oncology, Pharmacokinetics +17

A Prospective Study of Cognitive Function and Onset of Dementia in Cognitively Healthy Elders

Eugene H. Rubin, Martha Storandt, J. Philip Miller et al. · Archives of Neurology · 1998 · 322 citations

Medicine, Geriatric Medicine, Psychology +17

Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer

Oliver Wildner, John C. Morris, Nicholas N. Vahanian et al. · Gene Therapy · 1999 · 171 citations

Life Sciences, Molecular Biology, Oncology +12

Lymphatic Drainage Imaging of Breast Cancer in Mice by Micro-Magnetic Resonance Lymphangiography Using a Nano-Size Paramagnetic Contrast Agent

Hideaki Kobayashi, Satomi Kawamoto, Yoshiko Sakai et al. · JNCI Journal of the National Cancer Institute · 2004 · 152 citations

Medicine, Oncology, Radiology +17

Inhibition of nuclear factor-κB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinoma

Carter Van Waes, Angela A. Chang, Peter F. Lebowitz et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 117 citations

Medicine, Oncology, Radiation Oncology +16